Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR–Cas system by binding to target RNA and crRNA

Abstract CRISPR–Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) systems provide adaptive immunity against invasive nucleic acids guided by CRISPR RNAs (crRNAs) in archaea and bacteria. Type III CRISPR–Cas effector complexes show RNA cleavage and RNA-activated DNA cleavage activity, representing the only known system of dual nucleic acid interference. Here, we investigated the function of Cmr1 by genetic assays of DNA and RNA interference activity in the mutants and biochemical characterization of their mutated Cmr complexes. Three cmr1α mutants were constructed including ΔβΔ1α, Δβ1α-M1 and Δβ1α-M2 among which the last two mutants carried a double and a quadruple mutation in the first α-helix region of Cmr1α. Whereas the double mutation of Cmr1α (W58A and F59A) greatly influenced target RNA capture, the quadruple mutation almost abolished crRNA binding to Cmr1α. We found that Cmr2α-6α formed a stable core complex that is active in both RNA and DNA cleavage and that Cmr1α strongly enhances the basal activity of the core complex upon incorporation into the ribonucleoprotein complex. Therefore, Cmr1 functions as an integral activation module in III-B systems, and the unique occurrence of Cmr1 in III-B systems may reflect the adaptive evolution of type III CRISPR–Cas systems in thermophiles.

[1]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[2]  B. Graveley,et al.  RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex , 2009, Cell.

[3]  Jennifer A. Doudna,et al.  Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning , 2015, Science.

[4]  Matthias Mann,et al.  Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4. , 2014, Molecular cell.

[5]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[6]  Shiraz A. Shah,et al.  Genome Analyses of Icelandic Strains of Sulfolobus islandicus, Model Organisms for Genetic and Virus-Host Interaction Studies , 2011, Journal of bacteriology.

[7]  R. Garrett,et al.  Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers , 2011, Molecular microbiology.

[8]  M. F. White,et al.  Multiple nucleic acid cleavage modes in divergent type III CRISPR systems , 2016, Nucleic acids research.

[9]  Q. She,et al.  Unmarked gene deletion and host–vector system for the hyperthermophilic crenarchaeon Sulfolobus islandicus , 2009, Extremophiles.

[10]  Kira S. Makarova,et al.  Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems , 2016, Science.

[11]  Yan Zhang,et al.  Harnessing Type I and Type III CRISPR-Cas systems for genome editing , 2015, Nucleic acids research.

[12]  Q. She,et al.  An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference , 2014, Nucleic acids research.

[13]  Shiraz A Shah,et al.  CRISPR adaptive immune systems of Archaea , 2014, RNA biology.

[14]  M. F. White,et al.  A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction , 2016, Nucleic acids research.

[15]  X. Ao,et al.  The Sulfolobus Initiator Element Is an Important Contributor to Promoter Strength , 2013, Journal of bacteriology.

[16]  Emmanuelle Charpentier,et al.  DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes , 2015, FEMS microbiology reviews.

[17]  Scott Bailey,et al.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex. , 2016, Genes & development.

[18]  M. Rossi,et al.  Characterization of the Sulfolobus host–SSV2 virus interaction , 2006, Extremophiles.

[19]  R. Terns,et al.  Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex , 2014, Genes & development.

[20]  Sita J. Saunders,et al.  An updated evolutionary classification of CRISPR–Cas systems , 2015, Nature Reviews Microbiology.

[21]  Mariana J. Awayez,et al.  A Synthetic Arabinose-Inducible Promoter Confers High Levels of Recombinant Protein Expression in Hyperthermophilic Archaeon Sulfolobus islandicus , 2012, Applied and Environmental Microbiology.

[22]  B. Oh,et al.  Crystal structure and CRISPR RNA-binding site of the Cmr1 subunit of the Cmr interference complex. , 2014, Acta crystallographica. Section D, Biological crystallography.

[23]  Chikara Sato,et al.  Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. , 2015, Molecular cell.

[24]  J. Doudna,et al.  RNA-guided genetic silencing systems in bacteria and archaea , 2012, Nature.

[25]  Q. She,et al.  Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus , 2013, RNA biology.

[26]  E. Charpentier,et al.  Adaptation in CRISPR-Cas Systems. , 2016, Molecular cell.

[27]  Česlovas Venclovas,et al.  Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition. , 2016, Molecular cell.

[28]  Česlovas Venclovas,et al.  Type III CRISPR-Cas Immunity: Major Differences Brushed Aside. , 2017, Trends in microbiology.

[29]  Malcolm F. White,et al.  Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity , 2015, FEMS microbiology reviews.

[30]  K. Ye,et al.  Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex , 2014, Nucleic acids research.

[31]  Xu Peng,et al.  A novel interference mechanism by a type IIIB CRISPR‐Cmr module in Sulfolobus , 2013, Molecular microbiology.

[32]  Torsten Schwede,et al.  The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..

[33]  Q. She,et al.  Transcriptional regulator-mediated activation of adaptation genes triggers CRISPR de novo spacer acquisition , 2015, Nucleic acids research.

[34]  Michael S. Spilman,et al.  Structure of an RNA silencing complex of the CRISPR-Cas immune system. , 2013, Molecular cell.

[35]  Marco Biasini,et al.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..

[36]  Luciano A. Marraffini,et al.  Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity , 2015, Cell.

[37]  Torsten Schwede,et al.  Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.

[38]  Stan J. J. Brouns,et al.  CRISPR-Cas: Adapting to change , 2017, Science.

[39]  Joshua R. Elmore,et al.  Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system , 2016, Genes & development.

[40]  Rodolphe Barrangou,et al.  CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. , 2014, Molecular cell.

[41]  Albert J R Heck,et al.  Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. , 2013, Molecular cell.

[42]  Q. She,et al.  Genetic technologies for extremely thermophilic microorganisms of Sulfolobus, the only genetically tractable genus of crenarchaea , 2017, Science China Life Sciences.